Literature DB >> 11986093

A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy.

Roger E Turbin1, Charlotte R Thompson, John S Kennerdell, Kimberly Peele Cockerham, Mark J Kupersmith.   

Abstract

PURPOSE: Comparison of treatment outcome in patients with primary optic nerve sheath meningioma (ONSM).
DESIGN: Retrospective, nonrandomized, comparative interventional case series. PARTICIPANTS: Sixty-four patients with at least 50 months of well-documented follow-up. INTERVENTION: Observation, surgery only, radiotherapy only, or surgery and radiotherapy. MAIN OUTCOME MEASURES: Visual acuity expressed as ratio, radiographic progression, and treatment complications.
RESULTS: Sixty-four patients (55 women [85.9%] and nine men [14.1%]) were followed for a mean of 150.2 months (range, 51-516 months; standard deviation [SD], 74.7). The mean age at diagnosis was 47.1 years (range, 17-81 years; SD, 15.4). Fifty-eight patients had unilateral disease and six patients had bilateral disease. Of 59 patients with vision greater than no light perception at diagnosis, 13 patients were observed only, 12 had surgery only (four biopsies or partial resections, eight total resections), 18 received radiation alone, and 16 had surgery and radiation (14 biopsies or partial resections and radiation, two total resections and radiation). Irradiated patients received 4000 to 5500 cGy of conventional multiport or conformal external beam therapy, typically fractionated over 6 weeks. Visual acuity measurements at diagnosis among the four groups were not different (ratio, P = 0.186). Visual acuity at diagnosis was > or =0.5 in 56.3%, 0.4 to 0.050 in 12.5%, and <0.050 in 31.3%. Visual acuity measures at last follow-up were different among the four groups (ratio, P = 0.004). At last follow-up the acuity was > or =0.5 in 28.1%, 0.4 to 0.050 in 15.6%, and <0.050 in 56.3%. Visual acuity fell significantly for the observed only (ratio, P = 0.002), surgery only (ratio, P = 0.019), and surgery with radiation groups (ratio, P = 0.030). The radiation only group showed a decrease in visual acuity that was not significant (ratio, P = 0.301). Complication rate was 33.3% in radiation only cases, 66.7% in surgery only cases, and 62.5% in surgery with radiation cases. Twenty-one patients (32.8%) showed radiographic progression. Four patients who were observed, seven patients who had surgery alone, and eight patients who had surgery and radiation developed radiographic progression. Two patients who had radiation alone had radiographic progression before treatment. Only two patients treated with radiation only showed radiographic progression after radiotherapy, and both had at least one surgical procedure before the radiotherapy.
CONCLUSIONS: Patients with ONSM receiving radiation alone demonstrated the best visual outcome during the follow-up period. We recommend that fractionated external beam radiation (5000-5500 cGy) be considered as initial treatment in adults in selected cases of ONSM when preservation of visual function is a reasonable therapeutic goal.

Entities:  

Mesh:

Year:  2002        PMID: 11986093     DOI: 10.1016/s0161-6420(02)01017-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  36 in total

1.  The evolving management of optic nerve sheath meningiomas.

Authors:  N R Miller
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

2.  Stereotactic irradiation of biopsy proved optic nerve sheath meningioma.

Authors:  A D A Paridaens; R L J van Ruyven; W M H Eijkenboom; C M Mooy; W A van den Bosch
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

Review 3.  Fractionated radiotherapy for intracranial meningiomas.

Authors:  Vinai Gondi; Wolfgang A Tome; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

Review 4.  Loss of vision: imaging the visual pathways.

Authors:  H R Jäger
Journal:  Eur Radiol       Date:  2005-01-26       Impact factor: 5.315

5.  Biopsy of orbital meningioma by computed tomography-guided fine-needle aspiration.

Authors:  Yuriko Ban; Kiichiro Kusaba; Akihiko Miyao; Kazumi Akimoto; Kazuo Maki; Tomokatsu Yoshida
Journal:  Jpn J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.447

6.  Carcinoma of the breast metastatic to the optic nerve mimicking an optic nerve sheath meningioma: case report and review of the literature.

Authors:  Benjamin Fox; Paulette Pacheco; Franco DeMonte
Journal:  Skull Base       Date:  2005-11

Review 7.  Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.

Authors:  Leland Rogers; Igor Barani; Marc Chamberlain; Thomas J Kaley; Michael McDermott; Jeffrey Raizer; David Schiff; Damien C Weber; Patrick Y Wen; Michael A Vogelbaum
Journal:  J Neurosurg       Date:  2015-01       Impact factor: 5.115

Review 8.  Detection and treatment of optic nerve sheath meningioma.

Authors:  Mark L Moster
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

9.  Advances in multidisciplinary therapy for meningiomas.

Authors:  Priscilla K Brastianos; Evanthia Galanis; Nicholas Butowski; Jason W Chan; Ian F Dunn; Roland Goldbrunner; Christel Herold-Mende; Franziska M Ippen; Christian Mawrin; Michael W McDermott; Andrew Sloan; James Snyder; Ghazaleh Tabatabai; Marcos Tatagiba; Joerg C Tonn; Patrick Y Wen; Kenneth Aldape; Farshad Nassiri; Gelareh Zadeh; Michael D Jenkinson; David R Raleigh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

10.  [Meningioma of the anterior visual pathways. Epidemiology and clinical symptoms].

Authors:  H Wilhelm
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.